Ole Andreas Halvorsen - Viking Global Investors 13F Activity & Position Changes (Q4 2021)
According to the SEC 13F filed on Feb 14, 2022, the Viking Global Investors portfolio showed several notable changes in holdings as of quarter-end Dec 31, 2021. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q4 2021, the filing reported:
New Buys - American International Group, I, Amedisys Inc, Aon Plc, KE Holdings Inc, BioMarin Pharmaceutical Inc., and 15 more
Increases - Ameriprise Financial, Inc., Amazon.com, Inc., Avantor, Inc., Brookfield Asset Management Ltd., Boston Scientific Corporation, and 18 more
Reductions - Acadia Healthcare Company, Inc., AdaptHealth Corp., Assurant, Inc., Booking Holdings Inc. Common St, Bristol-Myers Squibb Company, and 24 more
Complete Exits - Align Technology, Inc., Atea Pharmaceuticals, Inc., Bilibili Inc., Fidelity National Information S, ICICI Bank Limited, and 8 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q4 2021
|
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-12,182
|
|
Q4 2021
|
AHCO
AdaptHealth Corp.
|
Sell |
-124,246
|
|
Q4 2021
|
AIG
American International Group, I
|
Buy - Position Entry |
+2,903,295
|
|
Q4 2021
|
AIZ
Assurant, Inc.
|
Sell |
-94,062
|
|
Q4 2021
|
ALGN
Align Technology, Inc.
|
Sell - Position Exit |
-111,570
|
|
Q4 2021
|
AMED
Amedisys Inc
|
Buy - Position Entry |
+391,131
|
|
Q4 2021
|
AMP
Ameriprise Financial, Inc.
|
Buy |
+52,929
|
|
Q4 2021
|
AMZN
Amazon.com, Inc.
|
Buy |
+75,291
|
|
Q4 2021
|
AON
Aon Plc
|
Buy - Position Entry |
+1,510,517
|
|
Q4 2021
|
AVIR
Atea Pharmaceuticals, Inc.
|
Sell - Position Exit |
-1,655,087
|
|
Q4 2021
|
AVTR
Avantor, Inc.
|
Buy |
+1,666,150
|
|
Q4 2021
|
BAM
Brookfield Asset Management Ltd.
|
Buy |
+615,996
|
|
Q4 2021
|
BEKE
KE Holdings Inc
|
Buy - Position Entry |
+2,920,256
|
|
Q4 2021
|
BILI
Bilibili Inc.
|
Sell - Position Exit |
-547,961
|
|
Q4 2021
|
BKNG
Booking Holdings Inc. Common St
|
Sell |
-6,125
|
|
Q4 2021
|
BMRN
BioMarin Pharmaceutical Inc.
|
Buy - Position Entry |
+2,869,947
|
|
Q4 2021
|
BMY
Bristol-Myers Squibb Company
|
Sell |
-5,207,645
|
|
Q4 2021
|
BSX
Boston Scientific Corporation
|
Buy |
+12,095,096
|
|
Q4 2021
|
CB
Chubb Limited
|
Buy |
+651,820
|
|
Q4 2021
|
CLDX
Celldex Therapeutics, Inc.
|
Sell |
-4,415
|
|
Q4 2021
|
CMCSA
Comcast Corporation
|
Buy |
+4,036,468
|
|
Q4 2021
|
CNC
Centene Corporation
|
Sell |
-1,265,468
|
|
Q4 2021
|
CRL
Charles River Laboratories Inte
|
Buy |
+212,726
|
|
Q4 2021
|
CTLT
Catalent, Inc.
|
Sell |
-23,680
|
|
Q4 2021
|
DAWN
Day One Biopharmaceuticals, Inc
|
Sell |
-53,972
|
|
Q4 2021
|
DE
Deere & Company
|
Buy |
+214,988
|
|
Q4 2021
|
FDX
FedEx Corporation
|
Buy - Position Entry |
+655,242
|
|
Q4 2021
|
FIS
Fidelity National Information S
|
Sell - Position Exit |
-7,172,066
|
|
Q4 2021
|
FTV
Fortive Corporation
|
Sell |
-2,323,331
|
|
Q4 2021
|
G76279101
Roivant Sciences
|
Buy - Position Entry |
+88,238,700
|
Page 1 of 3